Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. Schweiger joined the Cleveland Clinic in 2010, as Associate Staff, Center for Pediatric and Adolescent Endocrinology. She has a special interest in Adolescent Female Health and Type 1 Diabetes and has co-authored several publications in both areas.
Dr. Schweiger is the manager of the ESCALAIT (enrichment services and care for adolescents living with autoimmune insulin dependent type 1 diabetes) Clinic. This is a multidisciplinary clinic with an aim of helping to enhance the care and well being of adolescent females with type 1 diabetes. She is also the manager of the Jr. ESCALAIT, a multidisciplinary clinic with the aim of providing support and improving the care of children with type 1 diabetes ages 5 and younger.
She is one of the principal investigators on the Cleveland Clinic Healthy Girls project with the goal of obesity prevention in at risk young females. Dr. Schweiger also heads the Pediatric Diabetes Ketoacidosis Task Force at Cleveland Clinic Children’s Hospital with the goal of continuing to enhance the inpatient care children with diabetes. She has been an invited speaker at local and international conference on various topics in adolescent medicine and type 1 diabetes. She is a member of the following organizations: The American Diabetes Association, The Endocrine Society, and The Pediatric Endocrine Society.
androgen disorders, growth disorders, pubertal disorders, thyroid disease, congenital hyperinsulinism, calcium disorders, panhypopituitarism, PCOS, type 1 diabetes, type 2 diabetes, MODY, neonatal diabetes
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/28/2015, Dr. Schweiger has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.